ABT - Abbott Laboratories
261
$107.19
-$1.30 (-1.198%)
At market close
$107.01
-$0.18 (-0.167%)
Pre Market 3/20/26, 8:01 AM
Score3.79/5
Ownership Breakdown
Type | % Ownership | Market Value |
|---|---|---|
Insider | 0.47% | $879.53M |
Institutional | 81.83% | $152.42B |
Common & Other | 17.70% | $32.97B |
Insider Transactions
Buy Transactions
Sell Transactions
Insider Transaction Details
Sell, Grant, Buy, Exercise
Buy/Sell | Total Amount | Officer | Stock Price | Regulatory Filing Share Count | Regulatory Filing Shares | Date |
|---|
Sell | $30,397.54 | Cushman Elizabeth C. | $115.58 | -263.00 | 38.57K | 2026-03-02 |
Sell | $81,946.22 | Shroff Eric | $115.58 | -709.00 | 39.16K | 2026-03-02 |
Sell | $132,223.52 | Morrone Louis H.Executive VP - Core Diagnostics | $115.58 | -1,144.00 | 76.84K | 2026-03-02 |
Sell | $70,850.54 | Moreland Mary KExecutive VP - Human Resources | $115.58 | -613.00 | 104.29K | 2026-03-02 |
Sell | $67,614.30 | Mccoy John A. Jr.VP - Finance, Controller | $115.58 | -585.00 | 24.63K | 2026-03-02 |
Sell | $102,288.30 | Salvadori Daniel Gesua SiveExecutive VP, Group President - Established Pharmaceuticals and Nutritional Products | $115.58 | -885.00 | 146.38K | 2026-03-02 |
Sell | $165,205.46 | Cushman Elizabeth C. | $116.26 | -1,421.00 | 38.84K | 2026-02-27 |
Sell | $160,903.84 | Shroff Eric | $116.26 | -1,384.00 | 39.87K | 2026-02-27 |
Sell | $469,690.40 | Morrone Louis H.Executive VP - Core Diagnostics | $116.26 | -4,040.00 | 77.99K | 2026-02-27 |
Sell | $865,090.66 | Boudreau Philip PCFO, Executive VP - Finance | $116.26 | -7,441.00 | 71.17K | 2026-02-27 |